Jerald Radich, MD

Associate Editor

Dr. Radich is a Professor in the Clinical Research Division and Kurt Enslein Endowed Chair at Fred Hutch.

Articles by Jerald Radich, MD

Elias Jabbour, MDPrint | January 4, 2024

The Blood Cancers Today Editorial Board offers their thoughts on the past year.

Jerald Radich, MDAcute Myeloid Leukemia | January 17, 2024

"MRD positivity is an indication to go to transplant in these patients,” Dr. Radich said.

Jerald Radich, MDAcute Myeloid Leukemia | March 11, 2024

This editorial outlines treatments for relapsed AML, T-Cell activation, and more.

Sagar Lonial, MD, FACPViewpoints | February 8, 2024

The Blood Cancers Today Editorial Board reflects on the latest news in the field so far in 2023.

Elias Jabbour, MDViewpoints | January 4, 2023

As 2022 came to a close, the Blood Cancers Today Editorial Board shared their highlights from the year.

Jerald Radich, MDViewpoints | November 23, 2022

Jerald Radich, MD; and Christopher S. Hourigan, MD, DPhil, FACP, FRCP; discuss minimal residual disease.